Techniques in Coloproctology

, Volume 22, Issue 3, pp 215–221 | Cite as

The effect of metabolic syndrome on postoperative outcomes following laparoscopic colectomy

  • A. Zarzavadjian Le Bian
  • C. Denet
  • N. Tabchouri
  • H. Levard
  • R. Besson
  • T. Perniceni
  • R. Costi
  • P. Wind
  • D. Fuks
  • B. Gayet
Original Article



Among the criteria used to diagnose metabolic syndrome (MS), obesity and diabetes mellitus (DM) are associated with poor postoperative outcomes following colectomy. MS is also associated with colorectal cancer (CRC) and diverticulosis, both of which may be treated with colectomy. However, the effect of MS on postoperative outcomes following laparoscopic colectomy has yet to be clarified.


In an academic tertiary hospital, data from all consecutive patients undergoing laparoscopic colectomy from 2005 to 2014 were prospectively recorded and analysed. Patients presenting with MS [defined by the presence of three or more of the following criteria: elevated blood pressure, body mass index > 28 kg/m2, dyslipidemia (decreased serum HDL cholesterol, increased serum triglycerides) and increased fasting glucose/DM] were compared with patients without MS regarding peri-operative outcome [mainly anastomotic leaks, severe postoperative complications (Clavien–Dindo III and IV)] and mortality.


Overall, 1236 patients were included: 508 (41.1%) right colectomies and 728 (58.9%) left colectomies. Seven hundred seventy-two (62.4%) of these procedures were performed for CRC. MS was diagnosed in 85 (6.9%) patients, who were significantly older than the others (70 vs. 64.2 years, p < 0.001), and presented with more cardiac comorbidities (p < 0.001). MS was associated with increased blood loss (122.5 vs. 79.9 mL p = 0.001) and blood transfusion requirement (5.9 vs. 1.7%, p = 0.021). The anastomotic leak rate was 6.6% (with 2.2% of anastomotic leaks requiring surgical treatment), and the overall reoperation rate was 6.9%. The incidence of severe postoperative complications was 11.5%, and the overall mortality rate 0.6%. No differences were found between the groups in overall postoperative morbidity and mortality. Median length of stay was similar in both groups (7 days).


MS does not jeopardize postoperative outcomes following laparoscopic colectomy.


Metabolic syndrome Laparoscopic colectomy Postoperative outcomes Obesity Diabetes mellitus 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study, formal consent is not required.


  1. 1.
    Yeo HL, Isaacs AJ, Abelson JS, Milsom JW, Sedrakyan A (2016) Comparison of open, laparoscopic, and robotic colectomies using a large national database: outcomes and trends related to surgery center volume. Dis Colon Rectum 59:535–542CrossRefPubMedGoogle Scholar
  2. 2.
    Stocks T, Lukanova A, Bjorge T et al (2011) Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer 117:2398–2407CrossRefPubMedGoogle Scholar
  3. 3.
    Lu Y, Ness-Jensen E, Hveem K, Martling A (2015) Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway. Am J Epidemiol 182:883–893CrossRefPubMedGoogle Scholar
  4. 4.
    Kopylov U, Ben-Horin S, Lahat A, Segev S, Avidan B, Carter D (2012) Obesity, metabolic syndrome and the risk of development of colonic diverticulosis. Digestion 86:201–205CrossRefPubMedGoogle Scholar
  5. 5.
    Eckel RH, Alberti KG, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. Lancet 375:181–183CrossRefPubMedGoogle Scholar
  6. 6.
    Morita T, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S (2005) The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev 6:485–489PubMedGoogle Scholar
  7. 7.
    Lin JW, Caffrey JL, Chang MH, Lin YS (2010) Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality—cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 95:4258–4267CrossRefPubMedGoogle Scholar
  8. 8.
    Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR (2006) The metabolic syndrome and risk of incident colorectal cancer. Cancer 107:28–36CrossRefPubMedGoogle Scholar
  9. 9.
    Yki-Järvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diab Endocrinol 2:901–910CrossRefGoogle Scholar
  10. 10.
    Piscaglia F, Svegliati-Baroni G, Barchetti A et al (2016) HCC-NAFLD Italian Study Group. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatology 63:827–838CrossRefPubMedGoogle Scholar
  11. 11.
    Turati F, Talamini R, Pelucchi C et al (2013) Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer 108:222–228CrossRefPubMedGoogle Scholar
  12. 12.
    Lohsiriwat V, Pongsanguansuk W, Lertakyamanee N, Lohsiriwat D (2010) Impact of metabolic syndrome on the short-term outcomes of colorectal cancer surgery. Dis Colon Rectum 53:186–191CrossRefPubMedGoogle Scholar
  13. 13.
    Levard H, Denet C, Gayet B (2012) Laparoscopic right colectomy from top to bottom. J Visc Surg 149:e34–e37CrossRefPubMedGoogle Scholar
  14. 14.
    Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Tee MC, Ubl DS, Habermann EB et al (2016) Metabolic syndrome is associated with increased postoperative morbidity and hospital resource utilization in patients undergoing elective pancreatectomy. J Gastrointest Surg 20:189–198 (discussion 198) CrossRefPubMedGoogle Scholar
  16. 16.
    Zarzavadjian Le Bian A, Costi R, Sbai-Idrissi MS, Smadja C (2014) Liver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality. World J Gastroenterol 20:14455–14462CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Cauchy F, Zalinski S, Dokmak S et al (2013) Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. Br J Surg 100:113–121CrossRefPubMedGoogle Scholar
  18. 18.
    Makino T, Trencheva K, Shukla PJ et al (2014) The influence of obesity on short- and long-term outcomes after laparoscopic surgery for colon cancer: a case-matched study of 152 patients. Surgery 156:661–668CrossRefPubMedGoogle Scholar
  19. 19.
    Park JW, Lim SW, Choi HS, Jeong SY, Oh JH, Lim SB (2010) The impact of obesity on outcomes of laparoscopic surgery for colorectal cancer in Asians. Surg Endosc 24:1679–1685CrossRefPubMedGoogle Scholar
  20. 20.
    Makino T, Shukla PJ, Rubino F, Milsom JW (2012) The impact of obesity on perioperative outcomes after laparoscopic colorectal resection. Ann Surg 255:228–236CrossRefPubMedGoogle Scholar
  21. 21.
    Bamboat ZM, Kinnier C, Dursun A et al (2012) Short-term outcomes in obese patients after colectomy for adenocarcinoma at a bariatric center. J Gastrointest Surg 16:1923–1928CrossRefPubMedGoogle Scholar
  22. 22.
    Ziegler MA, Catto JA, Riggs TW, Gates ER, Grodsky MB, Wasvary HJ (2012) Risk factors for anastomotic leak and mortality in diabetic patients undergoing colectomy: analysis from a statewide surgical quality collaborative. Arch Surg 147:600–605CrossRefPubMedGoogle Scholar
  23. 23.
    Stein KB, Snyder CF, Barone BB et al (2010) Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 55:1839–1851CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Tsujinaka S, Konishi F, Kawamura YJ et al (2008) Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 51:1757–1765CrossRefPubMedGoogle Scholar
  25. 25.
    John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA (2006) Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 23:1511–1523CrossRefPubMedGoogle Scholar
  26. 26.
    Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E (2005) Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. AmJ Physiol Heart Circ Physiol 289:H228–H236CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Digestive Surgery, Avicenne HospitalParis XIII UniversityBobignyFrance
  2. 2.Laboratory of Medical Ethics and Legal MedicineDescartes University ParisParisFrance
  3. 3.Department of Digestive DiseasesMutualiste Montsouris Institute ParisParisFrance
  4. 4.Department of SurgeryUniversity of ParmaParmaItaly
  5. 5.Faculty of MedicineDescartes UniversityParisFrance

Personalised recommendations